Milrinone Lactate In Dextrose Injection, Solution
Product Images NDC 25021-313

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Milrinone Lactate In Dextrose (NDC 25021-313). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sagent Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Mil05 0001 01)

Structural Formula (Mil05 0001 01)
Chemical structure diagram of Milrinone Lactate showing molecular bonds and groups as part of its molecular formula representation.*
FDA Label Image

Package Label – Principal Display Panel – Bag Label (Mil05 0001 02)

Package Label – Principal Display Panel – Bag Label (Mil05 0001 02)
Label for Milrinone Lactate in 5% Dextrose Injection, an intravenous injection solution with strength 20 mg per 100 mL (0.2 mg/mL), in a 100 mL container. Manufactured for Sagent Pharmaceuticals. The label includes usage instructions and storage information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.